Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). It
Clonality:
Monoclonal
Concentration:
1 mg/mL.
Clone Designation:
[PSH0-73]
Buffer:
PBS (pH7.4).
Purity:
Protein A affinity purified.
Form:
Liquid
Target:
DXD
Antibody Type:
Primary Antibody
Application Dilute:
ELISA: 1:1,000
* VAT and and shipping costs not included. Errors and price changes excepted